These data demonstrated that CS suppressed the activation of CD4 + and CD8 + effector T cells in the lung during IAV infection at the early stage of infection (day 7), but led to increased numbers of IAV antigen-specific CD8 + and CD4 + T cells in the lung by day 10 p.i. Here, CD4 is linked to infection.